COMPASS Pathways plc (ADR)
General ticker "CMPS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $382.4M (TTM average)
COMPASS Pathways plc (ADR) follows the US Stock Market performance with the rate: 50.9%.
Estimated limits based on current volatility of 4.0%: low 5.02$, high 5.44$
Factors to consider:
- Total employees count: 166 (-10.8%) as of 2024
- Top business risk factors: Regulatory and compliance, Operational and conduct risks, Acquisition/divestiture risks, Labor/talent shortage/retention, Strategic risks and growth management
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.26$, 6.38$]
- 2025-12-31 to 2026-12-31 estimated range: [1.76$, 4.95$]
Financial Metrics affecting the CMPS estimates:
- Positive: with PPE of -1.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -44.70 <= 0.33
- Positive: -8.75 < Industry operating profit margin (median), % of -3.16
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Shareholder equity ratio, % of 72.40 > 63.39
Short-term CMPS quotes
Long-term CMPS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $110.40MM | $136.92MM | $178.21MM |
| Operating Income | $-110.40MM | $-136.92MM | $-178.21MM |
| Non-Operating Income | $19.31MM | $19.23MM | $24.68MM |
| Interest Expense | $0.00MM | $2.20MM | $4.48MM |
| R&D Expense | $65.05MM | $87.52MM | $119.04MM |
| Income(Loss) | $-91.10MM | $-117.68MM | $-153.53MM |
| Taxes | $0.41MM | $0.78MM | $1.59MM |
| Profit(Loss)* | $-91.50MM | $-118.46MM | $-155.12MM |
| Stockholders Equity | $181.28MM | $225.74MM | $154.69MM |
| Assets | $197.29MM | $275.99MM | $213.67MM |
| Operating Cash Flow | $-105.45MM | $-97.38MM | $-119.19MM |
| Capital expenditure | $0.60MM | $0.07MM | $0.00MM |
| Investing Cash Flow | $-0.60MM | $-0.06MM | $0.00MM |
| Financing Cash Flow | $1.04MM | $173.83MM | $63.82MM |
| Earnings Per Share** | $-2.16 | $-2.32 | $-2.30 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.